BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 10/06/2015

FDA Withdraws Ondansetron Injection Due to Safety or Effectiveness Concerns

The US Food and Drug Administration (FDA) has withdrawn Ondansetron (ondansetron hydrochloride) Injection, USP in a specific plastic container, due to concerns over its safety or effectiveness, and will no longer accept new applications for this product.

Source: Federal Register — Food and Drug AdministrationOpen original release →